AEHR TEST SYSTEMS (AEHR) Stock Fundamental Analysis
NASDAQ:AEHR • US00760J1088
39.72 USD
+0.49 (+1.25%)
Last: Feb 25, 2026, 09:38 AM
We assign a fundamental rating of 4 out of 10 to AEHR. AEHR was compared to 114 industry peers in the Semiconductors & Semiconductor Equipment industry. AEHR has a great financial health rating, but its profitability evaluates not so good. AEHR is valued quite expensive, but it does show an excellent growth.
1. Profitability
1.1 Basic Checks
- In the past year AEHR was profitable.
- In the past year AEHR has reported a negative cash flow from operations.
- The reported net income has been mixed in the past 5 years: AEHR reported negative net income in multiple years.
- The reported operating cash flow has been mixed in the past 5 years: AEHR reported negative operating cash flow in multiple years.
1.2 Ratios
- The Return On Assets of AEHR (-5.95%) is worse than 68.42% of its industry peers.
- The Return On Equity of AEHR (-6.77%) is worse than 64.04% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -5.95% | ||
| ROE | -6.77% | ||
| ROIC | N/A |
ROA(3y)12.71%
ROA(5y)8.78%
ROE(3y)15.26%
ROE(5y)9.32%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- The Gross Margin of AEHR (33.28%) is worse than 64.91% of its industry peers.
- In the last couple of years the Gross Margin of AEHR has grown nicely.
- AEHR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 33.28% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.48%
GM growth 5Y1.57%
2. Health
2.1 Basic Checks
- AEHR does not have a ROIC to compare to the WACC, probably because it is not profitable.
- AEHR has more shares outstanding than it did 1 year ago.
- The number of shares outstanding for AEHR has been increased compared to 5 years ago.
- There is no outstanding debt for AEHR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
- An Altman-Z score of 40.61 indicates that AEHR is not in any danger for bankruptcy at the moment.
- With an excellent Altman-Z score value of 40.61, AEHR belongs to the best of the industry, outperforming 93.86% of the companies in the same industry.
- There is no outstanding debt for AEHR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 40.61 |
ROIC/WACCN/A
WACC10.7%
2.3 Liquidity
- A Current Ratio of 10.62 indicates that AEHR has no problem at all paying its short term obligations.
- The Current ratio of AEHR (10.62) is better than 94.74% of its industry peers.
- AEHR has a Quick Ratio of 5.47. This indicates that AEHR is financially healthy and has no problem in meeting its short term obligations.
- With an excellent Quick ratio value of 5.47, AEHR belongs to the best of the industry, outperforming 81.58% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 10.62 | ||
| Quick Ratio | 5.47 |
3. Growth
3.1 Past
- AEHR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -96.67%.
- AEHR shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 243890.10% yearly.
- AEHR shows a small growth in Revenue. In the last year, the Revenue has grown by 4.96%.
- The Revenue has been growing by 21.48% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-96.67%
EPS 3Y-27.89%
EPS 5Y243890.1%
EPS Q2Q%-300%
Revenue 1Y (TTM)4.96%
Revenue growth 3Y5.07%
Revenue growth 5Y21.48%
Sales Q2Q%-26.53%
3.2 Future
- AEHR is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 20.92% yearly.
- Based on estimates for the next years, AEHR will show a quite strong growth in Revenue. The Revenue will grow by 18.08% on average per year.
EPS Next Y-185%
EPS Next 2Y-28.59%
EPS Next 3Y20.92%
EPS Next 5YN/A
Revenue Next Year-21.31%
Revenue Next 2Y12.28%
Revenue Next 3Y18.08%
Revenue Next 5YN/A
3.3 Evolution
- The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 1324.00, AEHR can be considered very expensive at the moment.
- AEHR's Price/Earnings ratio is a bit more expensive when compared to the industry. AEHR is more expensive than 63.16% of the companies in the same industry.
- When comparing the Price/Earnings ratio of AEHR to the average of the S&P500 Index (26.98), we can say AEHR is valued expensively.
- Based on the Price/Forward Earnings ratio of 519.22, the valuation of AEHR can be described as expensive.
- Based on the Price/Forward Earnings ratio, AEHR is valued a bit more expensive than 64.91% of the companies in the same industry.
- AEHR is valuated expensively when we compare the Price/Forward Earnings ratio to 28.01, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 1324 | ||
| Fwd PE | 519.22 |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- AEHR's earnings are expected to grow with 20.92% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)0.01
EPS Next 2Y-28.59%
EPS Next 3Y20.92%
5. Dividend
5.1 Amount
- AEHR does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
NASDAQ:AEHR (2/25/2026, 9:38:01 AM)
39.72
+0.49 (+1.25%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)01-08 2026-01-08/amc
Earnings (Next)04-06 2026-04-06
Inst Owners69.43%
Inst Owner Change3.42%
Ins Owners6.24%
Ins Owner Change1.54%
Market Cap1.22B
Revenue(TTM)53.25M
Net Income(TTM)-8.86M
Analysts76
Price Target24.82 (-37.51%)
Short Float %16.05%
Short Ratio4.38
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-8.29%
Min Revenue beat(2)-16.39%
Max Revenue beat(2)-0.19%
Revenue beat(4)1
Avg Revenue beat(4)-5.59%
Min Revenue beat(4)-16.39%
Max Revenue beat(4)1.05%
Revenue beat(8)3
Avg Revenue beat(8)-3.26%
Revenue beat(12)6
Avg Revenue beat(12)-1.32%
Revenue beat(16)8
Avg Revenue beat(16)1.18%
PT rev (1m)-1.35%
PT rev (3m)1.39%
EPS NQ rev (1m)-4.99%
EPS NQ rev (3m)-333.33%
EPS NY rev (1m)-87.49%
EPS NY rev (3m)-247.06%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-32.65%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-19.1%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 1324 | ||
| Fwd PE | 519.22 | ||
| P/S | 22.85 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 9.3 | ||
| P/tB | 11.07 | ||
| EV/EBITDA | N/A |
EPS(TTM)0.03
EY0.08%
EPS(NY)0.08
Fwd EY0.19%
FCF(TTM)-0.38
FCFYN/A
OCF(TTM)-0.17
OCFYN/A
SpS1.74
BVpS4.27
TBVpS3.59
PEG (NY)N/A
PEG (5Y)0.01
Graham Number1.7
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -5.95% | ||
| ROE | -6.77% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 33.28% | ||
| FCFM | N/A |
ROA(3y)12.71%
ROA(5y)8.78%
ROE(3y)15.26%
ROE(5y)9.32%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.48%
GM growth 5Y1.57%
F-Score4
Asset Turnover0.36
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 226.79% | ||
| Cap/Sales | 11.89% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 10.62 | ||
| Quick Ratio | 5.47 | ||
| Altman-Z | 40.61 |
F-Score4
WACC10.7%
ROIC/WACCN/A
Cap/Depr(3y)210.71%
Cap/Depr(5y)168.36%
Cap/Sales(3y)3.9%
Cap/Sales(5y)2.78%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-96.67%
EPS 3Y-27.89%
EPS 5Y243890.1%
EPS Q2Q%-300%
EPS Next Y-185%
EPS Next 2Y-28.59%
EPS Next 3Y20.92%
EPS Next 5YN/A
Revenue 1Y (TTM)4.96%
Revenue growth 3Y5.07%
Revenue growth 5Y21.48%
Sales Q2Q%-26.53%
Revenue Next Year-21.31%
Revenue Next 2Y12.28%
Revenue Next 3Y18.08%
Revenue Next 5YN/A
EBIT growth 1Y-1316.41%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-243.51%
EBIT Next 3Y87.64%
EBIT Next 5YN/A
FCF growth 1Y-282.8%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-166.21%
OCF growth 3YN/A
OCF growth 5YN/A
AEHR TEST SYSTEMS / AEHR FAQ
Can you provide the ChartMill fundamental rating for AEHR TEST SYSTEMS?
ChartMill assigns a fundamental rating of 4 / 10 to AEHR.
Can you provide the valuation status for AEHR TEST SYSTEMS?
ChartMill assigns a valuation rating of 1 / 10 to AEHR TEST SYSTEMS (AEHR). This can be considered as Overvalued.
What is the profitability of AEHR stock?
AEHR TEST SYSTEMS (AEHR) has a profitability rating of 1 / 10.
What is the financial health of AEHR TEST SYSTEMS (AEHR) stock?
The financial health rating of AEHR TEST SYSTEMS (AEHR) is 8 / 10.